Literature DB >> 29617590

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.

Willemien J van Driel1,2, Simone N Koole1, Gabe S Sonke1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29617590     DOI： 10.1056/NEJMc1802033

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

1.  Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience.

Authors:  Giulio Sozzi; Marco Petrillo; Roberto Berretta; Vito Andrea Capozzi; Giuseppe Paci; Giulia Musicò; Mariano Catello Di Donna; Virginia Vargiu; Federica Bernardini; Victor Lago; Santiago Domingo; Anna Fagotti; Giovanni Scambia; Vito Chiantera
Journal:  Arch Gynecol Obstet       Date:  2020-07-09       Impact factor: 2.344

Review 2.  Intraperitoneal chemotherapy for ovarian cancer with peritoneal metastases, systematic review of the literature and focused personal experience.

Authors:  Federico Coccolini; Paola Fugazzola; Giulia Montori; Luca Ansaloni; Massimo Chiarugi
Journal:  J Gastrointest Oncol       Date:  2021-04

3.  Hyperthermia potentiates cisplatin cytotoxicity and negative effects on mitochondrial functions in OVCAR-3 cells.

Authors:  Arturas Sukovas; Giedre Silkuniene; Sonata Trumbeckaite; Aldona Jasukaitiene; Laima Degutyte-Fomins; Vida Mildaziene; Antanas Gulbinas; Rasa Baniene; Zilvinas Dambrauskas; Saulius Paskauskas
Journal:  J Bioenerg Biomembr       Date:  2019-07-22       Impact factor: 2.945

4.  Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01).

Authors:  Ji Hyun Kim; Dong-Eun Lee; Yumi Lee; Hyeong In Ha; Yoon Jung Chang; Suk-Joon Chang; Sang-Yoon Park; Myong Cheol Lim
Journal:  J Gynecol Oncol       Date:  2022-05-31       Impact factor: 4.756

5.  Monoubiquitinated γ-H2AX: Abundant product and specific biomarker for non-apoptotic DNA double-strand breaks.

Authors:  Michal W Luczak; Anatoly Zhitkovich
Journal:  Toxicol Appl Pharmacol       Date:  2018-07-10       Impact factor: 4.219

6.  PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial.

Authors:  Mustafa Raoof; Gautam Malhotra; Adrian Kohut; Michael O'Leary; Paul Frankel; Thuy Tran; Marwan Fakih; Joseph Chao; Dean Lim; Yanghee Woo; Isaac B Paz; Michael Lew; Mihaela C Cristea; Lorna Rodriguez-Rodriguez; Yuman Fong; Andrew Blakely; Richard Whelan; Marc A Reymond; Amit Merchea; Thanh H Dellinger
Journal:  Ann Surg Oncol       Date:  2021-08-13       Impact factor: 5.344

7.  ASO Author Reflections: Defining the Role of PIPAC in the Treatment of Peritoneal Metastases.

Authors:  Mustafa Raoof; Thanh Dellinger
Journal:  Ann Surg Oncol       Date:  2021-07-26       Impact factor: 5.344

Review 8.  Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses.

Authors:  Niloy R Datta; H Petra Kok; Hans Crezee; Udo S Gaipl; Stephan Bodis
Journal:  Front Oncol       Date:  2020-06-12       Impact factor: 6.244

9.  The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer.

Authors:  Kate Glennon; Karen Mulligan; Kirsten Carpenter; Ruth Mooney; Jurgen Mulsow; Orla McCormack; William Boyd; Tom Walsh; Ruaidhri McVey; Claire Thompson; Brid Ryan; Katie Padfield; Patrick Murray; Donal J Brennan
Journal:  Gynecol Oncol Rep       Date:  2021-05-26

10.  The role of single-incision laparoscopic peritoneal exploration in the management of patients with peritoneal metastases.

Authors:  Haythem Najah; Brice Malgras; Anthony Dohan; Caroline Gronnier; Clarisse Eveno; Marc Pocard
Journal:  Surg Endosc       Date:  2019-07-18       Impact factor: 4.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.